Tongwang Yang (Dexi Chen)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Monoclonal Antibody

End Stage Renal Disease

Prognostic Factors

Cell Proliferation

Top Venues

Cell death & disease

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Haojun Wang, Quanwei Zhou, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang
LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell death & disease 15 (2) (2024)
Haojun Wang, Quanwei Zhou, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang
LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell death & disease 15 (2) (2024)
Haojun Wang, Quanwei Zhou, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang
LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell death & disease 15 (2) (2024)
Haojun Wang, Quanwei Zhou, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang
LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell death & disease 15 (2) (2024)
Yuxue Gao, Qingguo Xu, Xinqiang Li, Yuan Guo, Bowen Zhang, Yan Jin, Cunle Zhu, Yuntai Shen, Pengxiang Yang, Ying Shi, Rifeng Jin, Daojie Liu, Yabo Ouyang, Xiaoni Liu, Wenjing Wang, Dexi Chen, Tongwang Yang
Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2/STAT1 signal suppression in hepatocellular carcinoma. Cell death & disease 13 (3) (2022)
Tongwang Yang, Cunle Zhu, Ying Shi, Yuntai Shen, Yuxue Gao, Bowen Zhang, Rifeng Jin, Daojie Liu, Yabo Ouyang, Xiaoni Liu, Wenjing Wang, Pengxiang Yang, Qingguo Xu, Jin-Zhen Cai, Tongwang Yang
RDIVpSGP motif of ASPP2 binds to 14-3-3 and enhances ASPP2/k18/14-3-3 ternary complex formulation to promote BRAF/MEK/ERK signal inhibited cell proliferation in hepatocellular carcinoma. Cancer gene therapy 29 (11) (2022)